Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 1241: Which of the following drugs acts through inhibition of the integrase activity of the virus?

A. Raltegravir (Correct Answer)
B. Tipranavir
C. Enfuvirtide
D. Etravirine

Explanation: **Explanation:** The question tests your knowledge of **Antiretroviral Therapy (ART)** classification based on the HIV life cycle. **Correct Option: A. Raltegravir** Raltegravir is an **Integrase Strand Transfer Inhibitor (INSTI)**. Its mechanism of action involves binding to and inhibiting the viral enzyme **integrase**. This enzyme is responsible for inserting (integrating) the HIV viral DNA into the host cell's genome. By blocking this step, the virus cannot replicate. Other drugs in this class include Dolutegravir and Elvitegravir. **Incorrect Options:** * **B. Tipranavir:** This is a **Protease Inhibitor (PI)**. It inhibits the viral protease enzyme, preventing the cleavage of polyproteins into functional mature proteins, resulting in the production of immature, non-infectious virions. * **C. Enfuvirtide:** This is a **Fusion Inhibitor**. It binds to the **gp41** subunit of the viral envelope protein, preventing the fusion of the HIV membrane with the host CD4 cell membrane. * **D. Etravirine:** This is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)**. It binds directly to the reverse transcriptase enzyme at a site different from the active site (allosteric inhibition), preventing the conversion of viral RNA to DNA. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for INSTIs:** All drugs in this class contain **"-tegra-"** (Integrase), e.g., Ral**tegra**vir, Dolu**tegra**vir. * **Dolutegravir** is currently the preferred first-line agent in WHO and NACO guidelines due to its high genetic barrier to resistance. * **Raltegravir** is known for causing an increase in **creatine kinase** and potential myopathy. * **Maraviroc** (another entry inhibitor) acts by blocking the **CCR5 receptor** on the host cell, unlike Enfuvirtide which acts on the virus.

Question 1242: Which of the following drugs is effective against Pseudomonas infection?

A. Ampicillin
B. Ceftriaxone
C. Colistin (Correct Answer)
D. Cefixime

Explanation: **Explanation:** **Pseudomonas aeruginosa** is a notorious Gram-negative pathogen known for its intrinsic resistance to many standard antibiotics. **Why Colistin is Correct:** Colistin (Polymyxin E) is a rapidly bactericidal drug that acts like a detergent, disrupting the outer cell membrane of Gram-negative bacteria [1]. It is considered a **"last-resort" antibiotic** specifically reserved for multidrug-resistant (MDR) Gram-negative infections, including *Pseudomonas aeruginosa*, *Acinetobacter*, and *Klebsiella pneumoniae* [1]. Due to its significant nephrotoxicity and neurotoxicity, it is used primarily when other safer anti-pseudomonal agents fail. **Why the other options are incorrect:** * **Ampicillin:** An amino-penicillin that is effective against certain Gram-positive and some Gram-negative organisms (like *E. coli*), but it is completely inactivated by the beta-lactamases produced by *Pseudomonas*. * **Ceftriaxone:** A 3rd-generation cephalosporin. While it has broad Gram-negative coverage, it notably **lacks activity** against *Pseudomonas*. (Note: Ceftazidime and Cefoperazone are the only 3rd-gen cephalosporins with anti-pseudomonal activity). * **Cefixime:** An oral 3rd-generation cephalosporin primarily used for respiratory and urinary tract infections; it has no clinical efficacy against *Pseudomonas*. **High-Yield Clinical Pearls for NEET-PG:** * **Anti-pseudomonal Penicillins:** Piperacillin, Ticarcillin. * **Anti-pseudomonal Cephalosporins:** Ceftazidime (3rd gen), Cefoperazone (3rd gen), Cefepime (4th gen). * **Carbapenems:** Imipenem, Meropenem, and Doripenem (Note: **Ertapenem** does NOT cover Pseudomonas). * **Fluoroquinolones:** Ciprofloxacin and Levofloxacin are the only oral options. * **Monobactams:** Aztreonam. * **Aminoglycosides:** Amikacin, Gentamicin, and Tobramycin.

Question 1243: What is the drug of choice for preventing fetal toxoplasmosis infection during pregnancy?

A. Pyrimethamine
B. Sulfadiazine
C. Spiramycin (Correct Answer)
D. Pyrimethamine + Sulfadiazine

Explanation: **Explanation:** The management of toxoplasmosis in pregnancy depends on whether the fetus has been infected. **Spiramycin** is the drug of choice for **preventing** vertical transmission from the mother to the fetus. **1. Why Spiramycin is correct:** Spiramycin is a macrolide antibiotic that achieves high concentrations in the **placenta**. It does not cross the placental barrier in significant amounts, meaning it treats the mother and "clears" the placenta of parasites, thereby preventing the transmission to the fetus. It is safe to use throughout pregnancy. **2. Why the other options are incorrect:** * **Pyrimethamine (A) & Sulfadiazine (B):** These drugs are folic acid antagonists [1]. Pyrimethamine is potentially **teratogenic** (especially in the first trimester) and can cause bone marrow suppression. * **Pyrimethamine + Sulfadiazine (D):** This combination is the **treatment of choice** only if fetal infection is **confirmed** (via amniotic fluid PCR or ultrasound findings). Unlike Spiramycin, these drugs cross the placenta to treat the fetus directly. They are typically administered after the 18th week of gestation along with Folinic acid (Leucovorin) to prevent maternal toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad of Congenital Toxoplasmosis:** Chorioretinitis, Hydrocephalus, and Intracranial calcifications. * **Spiramycin:** Used for prophylaxis (prevention of transmission). * **Pyrimethamine + Sulfadiazine + Folinic Acid:** Used for confirmed fetal infection or neonatal disease. * **Alternative:** Clindamycin can be used in patients allergic to Sulfonamides.

Question 1244: If a patient develops resistance to isoniazid, to which drug will they simultaneously develop resistance?

A. Streptomycin
B. Rifampicin (Correct Answer)
C. Ethambutol
D. Pyrazinamide

Explanation: **Explanation:** The correct answer is **Rifampicin**. This phenomenon is primarily based on the clinical definition of **Multidrug-Resistant Tuberculosis (MDR-TB)** and the epidemiological patterns of resistance in *Mycobacterium tuberculosis*. **Why Rifampicin is correct:** In clinical practice, resistance to Isoniazid (INH) is often the first step in the development of MDR-TB. According to WHO and RNTCP guidelines, MDR-TB is defined specifically as resistance to **at least Isoniazid and Rifampicin**. Statistically, if a patient develops resistance to INH, there is a high clinical probability that they will also harbor or rapidly develop resistance to Rifampicin due to poor compliance or inadequate treatment regimens. While the molecular mechanisms differ (INH involves *katG* or *inhA* mutations; Rifampicin involves *rpoB* mutations), they are linked by the definition of MDR-TB. **Why other options are incorrect:** * **Streptomycin:** Resistance is usually due to mutations in the *rpsL* or *rrs* genes. It is an aminoglycoside and does not share a common resistance pathway or mandatory clinical grouping with INH. * **Ethambutol:** Resistance involves the *embB* gene. While it is part of the first-line regimen, resistance to INH does not automatically imply resistance to Ethambutol. * **Pyrazinamide:** Resistance is linked to the *pncA* gene. It remains effective in many INH-resistant cases unless the strain has progressed to extensive resistance. **High-Yield Clinical Pearls for NEET-PG:** * **MDR-TB Definition:** Resistance to **INH + Rifampicin** (with or without other drugs). * **XDR-TB Definition:** MDR-TB + resistance to any **Fluoroquinolone** + at least one **Second-line injectable** (Amikacin, Kanamycin, or Capreomycin). *Note: Newer definitions focus on Bedaquiline/Linezolid.* * **Mechanism of INH:** Inhibits mycolic acid synthesis; requires activation by the **catalase-peroxidase (katG)** enzyme. * **Most common mutation for INH resistance:** *katG* gene (high-level resistance).

Question 1245: What is the drug of choice for gonococcal and non-gonococcal urethritis?

A. Clindamycin
B. Cefepime
C. Metronidazole
D. Azithromycin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Azithromycin**. **Why Azithromycin is the Correct Choice:** Urethritis is often "mixed," involving both *Neisseria gonorrhoeae* (gonococcal) and *Chlamydia trachomatis* (non-gonococcal). Azithromycin, a macrolide, is highly effective against *Chlamydia*. While cephalosporins (like Ceftriaxone) are typically the first-line treatment for Gonorrhea, Azithromycin is frequently co-administered to cover potential Chlamydial infection and to combat increasing gonococcal resistance. In many syndromic management protocols (like the WHO and NACO guidelines), a single 1g dose of Azithromycin is a cornerstone for treating uncomplicated urethritis. **Analysis of Incorrect Options:** * **Clindamycin (A):** This lincosamide is primarily used for anaerobic infections and Gram-positive cocci (like MRSA). It has no significant activity against *N. gonorrhoeae* or *C. trachomatis*. * **Cefepime (B):** This is a 4th-generation cephalosporin with broad-spectrum activity, including *Pseudomonas*. While it has Gram-negative coverage, it is not the standard of care for urethritis; 3rd-generation Ceftriaxone is the preferred cephalosporin for Gonorrhea. * **Metronidazole (C):** This is an antiprotozoal and anaerobic agent. It is the drug of choice for *Trichomonas vaginalis* or Bacterial Vaginosis, but it does not cover the primary bacterial causes of urethritis. **High-Yield Clinical Pearls for NEET-PG:** * **Syndromic Management (NACO):** For urethral discharge (Grey Kit), the treatment is a single dose of **Azithromycin (1g)** plus **Cefixime (400mg)**. * **Mechanism:** Azithromycin inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**. * **Chlamydia Treatment:** If Azithromycin is not used, **Doxycycline** (100mg BID for 7 days) is the alternative first-line agent for non-gonococcal urethritis.

Question 1246: Which of the following is the drug of choice for invasive aspergillosis?

A. Voriconazole (Correct Answer)
B. Posaconazole
C. Amphotericin B
D. Caspofungin

Explanation: **Explanation:** **Voriconazole** is the current **drug of choice (DOC)** for invasive aspergillosis. This recommendation is based on clinical trials demonstrating that voriconazole provides superior efficacy and better survival rates compared to conventional Amphotericin B, along with a more favorable safety profile. **Mechanism of Action:** Voriconazole is a second-generation triazole that inhibits the enzyme **14-α-demethylase**, thereby blocking the synthesis of ergosterol, a vital component of the fungal cell membrane. **Analysis of Options:** * **Voriconazole (Option A):** Correct. It is the primary treatment for most forms of invasive aspergillosis. * **Posaconazole (Option B):** While highly effective against *Aspergillus*, it is primarily used for **prophylaxis** in immunocompromised patients (e.g., neutropenic patients) or as salvage therapy when first-line agents fail. * **Amphotericin B (Option C):** Previously the gold standard, it is now considered an alternative (specifically the Liposomal formulation) due to significant nephrotoxicity and lower efficacy compared to voriconazole. * **Caspofungin (Option D):** An echinocandin used as salvage therapy or in combination for refractory cases; it is not used as monotherapy for initial treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of Voriconazole:** Distinctive **visual disturbances** (photopsia/blurring) occur in ~30% of patients. It is also associated with photosensitivity dermatitis and hepatic enzyme elevation. * **Alternative DOC:** **Isavuconazole** is another first-line agent for invasive aspergillosis, often preferred if the patient has renal impairment or if there is a suspicion of co-infection with Mucormycosis. * **DOC for Allergic Bronchopulmonary Aspergillosis (ABPA):** Oral **Itraconazole** (along with corticosteroids).

Question 1247: What is the drug of choice for uncomplicated cystitis?

A. Amoxicillin
B. Chloramphenicol
C. Cotrimoxazole
D. Fosfomycin (Correct Answer)

Explanation: **Explanation:** The drug of choice for **uncomplicated cystitis** (lower urinary tract infection in non-pregnant women) has shifted in recent years due to increasing resistance patterns. **Fosfomycin** (single 3g dose) and **Nitrofurantoin** are now considered first-line agents. **Why Fosfomycin is correct:** Fosfomycin is a bactericidal antibiotic that inhibits cell wall synthesis by inhibiting the enzyme **enolpyruvate transferase (MurA)**. It is highly effective against common uropathogens, including *E. coli* and *E. faecalis*. Its primary advantage is its unique pharmacokinetic profile: a single oral dose achieves high concentrations in the urine that remain therapeutic for up to 48–72 hours, ensuring high patient compliance. **Why other options are incorrect:** * **Amoxicillin:** No longer used empirically for UTIs due to high rates of resistance among *E. coli* strains. It is only used if the organism is known to be susceptible. * **Chloramphenicol:** Primarily used for enteric fever or bacterial meningitis (in specific cases). It is not indicated for UTIs due to its significant toxicity profile (e.g., bone marrow suppression). * **Cotrimoxazole:** Previously a first-line drug, it is now reserved for cases where local resistance rates are known to be low (<20%). Widespread resistance has diminished its utility as a primary choice. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Fosfomycin inhibits the first step of peptidoglycan synthesis (conversion of NAG to NAM). * **Pregnancy:** Both Fosfomycin and Nitrofurantoin are generally considered safe in pregnancy (Category B), though Nitrofurantoin should be avoided at term. * **Nitrofurantoin Note:** It is ineffective in pyelonephritis (upper UTI) because it does not achieve therapeutic concentrations in the renal parenchyma.

Question 1248: Which antibiotic accentuates the neuromuscular blockade produced by pancuronium?

A. Streptomycin (Correct Answer)
B. Erythromycin
C. Penicillin G
D. Chloramphenicol

Explanation: The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Aminoglycosides (like Streptomycin, Gentamicin, and Neomycin) are well-known for their ability to produce neuromuscular blockade [2]. They act by two primary mechanisms: * **Presynaptic:** They inhibit the release of Acetylcholine (ACh) from the motor nerve terminal by competing with Calcium ions at the voltage-gated calcium channels [2]. * **Postsynaptic:** They reduce the sensitivity of the nicotinic ACh receptors at the motor endplate. When administered with non-depolarizing neuromuscular blockers like **Pancuronium**, aminoglycosides act synergistically, significantly prolonging and intensifying the muscle paralysis [1]. This effect can be partially reversed by Calcium gluconate or Neostigmine [1]. **2. Why the other options are incorrect:** * **Erythromycin:** While Macrolides are potent enzyme inhibitors (CYP450), they do not possess intrinsic neuromuscular blocking properties. * **Penicillin G:** Beta-lactams primarily act on cell wall synthesis and do not interfere with the neuromuscular junction. * **Chloramphenicol:** This drug inhibits bacterial protein synthesis (50S subunit) but does not affect calcium channels or ACh release at the motor endplate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Order of Potency for NM Blockade:** Neomycin > Streptomycin > Amikacin > Gentamicin. * **Contraindication:** Aminoglycosides are strictly contraindicated in patients with **Myasthenia Gravis** as they can precipitate a severe myasthenic crisis. * **Other drugs that potentiate NM blockers:** Magnesium salts, Calcium channel blockers, Volatile anesthetics (Isoflurane), and Quinidine. * **Management:** Intravenous **Calcium Gluconate** is the preferred treatment to antagonize aminoglycoside-induced blockade.

Question 1249: Disulfiram-like reaction is commonly caused by which of the following?

A. Penicillin
B. Metronidazole (Correct Answer)
C. Tetracycline
D. Erythromycin

Explanation: **Explanation:** **Metronidazole** is the correct answer because it inhibits the enzyme **aldehyde dehydrogenase**. Under normal conditions, alcohol is metabolized into acetaldehyde, which is then converted into acetic acid by aldehyde dehydrogenase. When this enzyme is inhibited, acetaldehyde accumulates in the blood, leading to a "Disulfiram-like reaction." [2] Symptoms include intense flushing, tachycardia, palpitations, nausea, vomiting, and hypotension. Patients must be advised to avoid alcohol during and for at least 48–72 hours after completing metronidazole therapy. **Analysis of Incorrect Options:** * **A. Penicillin:** These are beta-lactam antibiotics that inhibit cell wall synthesis. They are not associated with alcohol metabolism interference. * **C. Tetracycline:** These inhibit the 30S ribosomal subunit. While they have several side effects (e.g., photosensitivity, teeth discoloration), they do not cause disulfiram-like reactions. * **D. Erythromycin:** A macrolide that inhibits the 50S subunit. It is a potent CYP450 inhibitor but does not affect aldehyde dehydrogenase. [1] **Clinical Pearls for NEET-PG:** * **Other drugs causing Disulfiram-like reactions:** * **Cephalosporins:** Specifically those containing the **Methylthiotetrazole (MTT) side chain** (e.g., Cefotetan, Cefoperazone, Cefamandole). * **Sulfonylureas:** First-generation agents like Chlorpropamide. * **Others:** Procarbazine (anticancer), Griseofulvin (antifungal), and Tinidazole. * **Mnemonic:** "Many Compounds Can Cause Terrible Reactions" (Metronidazole, Chlorpropamide, Cephalosporins, Cefotetan, Tinidazole, Retinoids/Griseofulvin).

Question 1250: Which of the following statements is true regarding Atazanavir?

A. Effective against only HIV-1
B. Resistance is due to mutation in codon 50 isoleucine to valine substitution (Correct Answer)
C. Decreases cholesterol and triglyceride levels
D. Combination with ritonavir has no advantage

Explanation: **Explanation:** Atazanavir is an **aza-peptide Protease Inhibitor (PI)** used in the management of HIV. Understanding its resistance profile and metabolic impact is crucial for NEET-PG. **1. Why Option B is Correct:** Resistance to Atazanavir is unique compared to other PIs. It typically develops through a specific **"signature mutation"** at **codon 50 (I50L)**, where isoleucine is substituted by leucine (or sometimes valine, **I50V**). This mutation results in high-level resistance to Atazanavir but, interestingly, often increases the susceptibility of the virus to other protease inhibitors. **2. Why Other Options are Incorrect:** * **Option A:** Atazanavir is effective against **both HIV-1 and HIV-2**, similar to most other protease inhibitors. * **Option C:** Unlike older PIs (like Lopinavir), Atazanavir is known for its **"lipid-neutral"** profile. It does not significantly increase cholesterol or triglycerides; however, it does not *decrease* them either. Its most notable side effect is **unconjugated hyperbilirubinemia** (due to UGT1A1 inhibition). * **Option D:** Combining Atazanavir with **Ritonavir** (Pharmacokinetic Boosting) is highly advantageous. Ritonavir inhibits CYP3A4, thereby increasing the half-life and plasma concentration of Atazanavir, allowing for once-daily dosing and better efficacy. **High-Yield Clinical Pearls for NEET-PG:** * **Absorption:** Atazanavir requires an **acidic gastric pH** for absorption. Therefore, it should not be co-administered with Proton Pump Inhibitors (PPIs). * **Side Effect:** It causes benign, asymptomatic **indirect hyperbilirubinemia** (jaundice without transaminitis). * **ECG Changes:** It may cause **PR interval prolongation** in some patients. * **Preferred PI:** Due to its once-daily dosing and lack of metabolic (lipid/glucose) side effects, it is often preferred over older PIs.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free